Fab antibody fragment-functionalized liposomes for specific targeting of antigen-positive cells

dc.commentsCEB46971por
dc.contributor.authorOhradanova-Repic, Annapor
dc.contributor.authorNogueira, E.por
dc.contributor.authorHartl, Ingridpor
dc.contributor.authorGomes, Andreia Cpor
dc.contributor.authorPreto, Anapor
dc.contributor.authorSteinhuber, Evapor
dc.contributor.authorMühlgrabner, Vanessapor
dc.contributor.authorRepic, Markopor
dc.contributor.authorKuttke, Mariopor
dc.contributor.authorZwirzitz, Alexanderpor
dc.contributor.authorProuza, Marekpor
dc.contributor.authorSuchanek, Miloslavpor
dc.contributor.authorWozniak-Knopp, Gordanapor
dc.contributor.authorHorejsi, Vaclavpor
dc.contributor.authorSchabbauer, Gernotpor
dc.contributor.authorCavaco-Paulo, Arturpor
dc.contributor.authorStockinger, Hannespor
dc.date.accessioned2018-02-27T23:44:22Z
dc.date.available2018-02-27T23:44:22Z
dc.date.issued2018
dc.date.updated2018-01-03T23:42:05Z
dc.description.abstractLiposomes functionalized with monoclonal antibodies or their antigen-binding fragments have attracted much attention as specific drug delivery devices for treatment of various diseases including cancer. The conjugation of antibodies to liposomes is usually achieved by covalent coupling using cross-linkers in a reaction that might adversely affect the characteristics of the final product. Here we present an alternative strategy for liposome functionalization: we created a recombinant Fab antibody fragment genetically fused on its C-terminus to the hydrophobic peptide derived from pulmonary surfactant protein D, which became inserted into the liposomal bilayer during liposomal preparation and anchored the Fab onto the liposome surface. The Fab-conjugated liposomes specifically recognized antigen-positive cells and efficiently delivered their cargo, the Alexa Fluor 647 dye, into target cells in vitro and in vivo. In conclusion, our approach offers the potential for straightforward development of nanomedicines functionalized with an antibody of choice without the need of harmful cross-linkers.por
dc.description.publicationversioninfo:eu-repo/semantics/publishedVersionpor
dc.description.sponsorshipThis work has received funding from the European Union's Seventh Framework Program (FP7/2007-2013; grant agreement NMP4-LA-2009-228827 NANOFOL) and Horizon 2020 Research and Innovation Program (grant agreement No 683356 - FOLSMART), further from the Portuguese Foundation for Science and Technology under the scope of the strategic funding of UID/BIO/04469/2013 unit and COMPETE 2020 (POCI-01-0145-FEDER-006684) and BioTecNorte operation (NORTE-01-0145-FEDER-000004) funded by the European Regional Development Fund under the scope of Norte2020.por
dc.distributioninternationalpor
dc.identifier.citationOhradanova-Repic, Anna; Nogueira, E.; Hartl, Ingrid; Gomes, Andreia C.; Preto, Ana; Steinhuber, Eva; Mühlgrabner, Vanessa; Repic, Marko; Kuttke, Mario; Zwirzitz, Alexander; Prouza, Marek; Suchanek, Miloslav; Wozniak-Knopp, Gordana; Horejsi, Vaclav; Schabbauer, Gernot; Cavaco-Paulo, Artur; Stockinger, Hannes, Fab antibody fragment-functionalized liposomes for specific targeting of antigen-positive cells. Nanomedicine-Nanotechnology Biology and Medicine, 14(1), 123-130, 2018. doi: 10.1016/j.nano.2017.09.003por
dc.identifier.doi10.1016/j.nano.2017.09.003por
dc.identifier.eissn1549-9642por
dc.identifier.issn15499634por
dc.identifier.pmid28939491por
dc.identifier.urihttps://hdl.handle.net/1822/51164
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherElsevierpor
dc.relationFP7/2007-2013por
dc.relationNMP4-LA-2009-228827por
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FBIO%2F04469%2F2013/PTpor
dc.relationPOCI-01-0145-FEDER-006684por
dc.relationNORTE-01-0145-FEDER-000004por
dc.relation.publisherversionhttp://www.nanomedjournal.com/por
dc.rightsopenAccesspor
dc.subjectActive targetingpor
dc.subjectLiposome functionalizationpor
dc.subjectImmunoliposomepor
dc.subjectAntibody engineeringpor
dc.subjectRecombinant Fab antibody fragmentpor
dc.subject.wosScience & Technologypor
dc.titleFab antibody fragment-functionalized liposomes for specific targeting of antigen-positive cellspor
dc.typearticle
dspace.entity.typePublicationen
oaire.citationConferencePlaceNetherlands
oaire.citationEndPage130por
oaire.citationIssue1por
oaire.citationStartPage123por
oaire.citationVolume14por
sdum.journalNanomedicine: Nanotechnology, Biology, and Medicinepor

Ficheiros

Pacote original

A mostrar 1 - 1 de 1
A carregar...
Nome:
document_46971_1.pdf
Tamanho:
1.03 MB
Formato:
Adobe Portable Document Format